Capital Flow Monitor · Sponsors · CIK 1869338
ADvantage Therapeutics, Inc.
195 NW 40th Street, Miami, FL, 33140 · 630-886-7345
Other Health Care · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$25.4M
Sold
$13.7M
% sold
54.0%
Investors
24
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-28 | D/A ·current | 506(b) | $25.4M | $13.7M | 54.0% | 24 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Agustin Fernandez Santana III — Executive Officer / Director, Miami, FL
1 other raise
- Klothea Bio, Inc. $6.9M of $10.4M · 66.3%
-
Jeffrey B. Madden — Executive Officer / Director, Miami, FL
1 other raise
- Klothea Bio, Inc. $6.9M of $10.4M · 66.3%
- Frank Mattner — Director, Miami, FL
-
Walter Schmidt — Director, Miami, FL
1 other raise
- Klothea Bio, Inc. $6.9M of $10.4M · 66.3%
- David Buchsbaum — Executive Officer, Miami, FL
Placement agents
- Corporate Partners & Co. Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.